Label Changes for:

Lotensin (benazepril hydrochloride) tablets

November 2009

Changes have been made to the CONTRAINDICATIONS sections of the safety label.

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – November 2009

CONTRAINDICATIONS

  • Lotensin is also contraindicated in patients with a history of angioedema with or without previous ACE inhibitor treatment.
Hide
(web4)